Back to the complete issue
Tuesday, 16 July 2019

EDA gets sharper teeth under newly passed legislation

LEGISLATION WATCH- EDA’s mandate expands under new pharma legislation: The Health Ministry will transfer regulatory powers over the pharma market to the Egyptian Drug Authority (EDA) under legislation passed by the House last week, the local press reported. The EDA will now be in charge of registering new products, maintaining production standards, and setting customs rates on imported products. The Prime Minister must issue the executive regulations of the legislation within six months of its announcement in the official gazette. Here’s a breakdown of the legislation:

  • The National Organization for Drug & Control Research and the Drug Planning and Policies Fund will be dissolved, with the EDA receiving the budgets and responsibilities of both organizations. Some employees will be transferred to the EDA while others will be moved to other public sector entities;
  • EDA employees will be allowed to enter facilities to supervise and inspect them if approved by the justice minister;
  • The EDA will be able to set up companies by itself or in partnership with existing companies. It will be part-funded via returns on its investments and sales, and will be exempt from paying preliminary or final insurance fees on purchases;
  • The Egyptian Authority for the Unified Procurement of Medical Supply and Technology will be in charge of making available medical products and appliances for all government entities.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Mashreq (tax ID: 204-898-862), the MENA region’s leading homegrown personal and digital bank; Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt; Hassan Allam Properties (tax ID:  553-096-567), one of Egypt’s most prominent and leading builders; and Saleh, Barsoum & Abdel Aziz (tax ID: 220-002-827), the leading audit, tax and accounting firm in Egypt.